The present invention discloses a compound with structural formula I or its pharmaceutically acceptable salt, and its application for cancer treatment. More particularly in the field of cancer treatment, the present invention is especially applied for leukemia treatment and the pharmaceutical composition containing the compound and the composition with other pharmaceutical agents.